News

Results may represent a retinal degenerative change.

Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.

Despite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.

The EURETINA 2021 Virtual Meeting is scheduled for September 9 to 12, 2021, and retina specialists eagerly await the showcase of cutting-edge scientific developments.

This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.

Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.

Outlook Therapeutics completes Phase 3 NORSE TWO safety and efficacy trial for ONS-5010, an investigational ophthalmic formulation of bevacizumab for treatment of wet AMD.

The U.S. FDA granted orphan drug designation to ADX-2191, methotrexate for intravitreal injection, as treatment for retinitis pigmentosa.

FDA will be asked to consider ONS-5010 for treating wet AMD.

New opportunities continue to develop in an evolving landscape.

With orphan drug and fast track status, Neurotech plans to seek FDA approval for its NT-501 Implant platform late next year.

Investigators have found that 78% of neovascular AMD cases have been detected using the PHP home monitoring system.

A team of investigators used corneal confocal microscopy to identify corneal nerve damage in cases of long COVID-19.

The American Society of Cataract and Refractive Surgery hosted its 2021 ASCRS and ASOA Annual Meeting July 23-27 in Las Vegas, Nevada.

Nanoscope Therapeutics Inc. has dosed its first patient in a late-stage Phase 2b trial of a gene therapy that delivers multi-characteristic opsin to retinal cells.

A team of investigators found that the retina may offer signs of COVID-19 infection before symptoms present.

Why investigators are considering AMD to be a disease spectrum rather than a single disease.

Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.

Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.

A poll for ophthalmologists and retina specialists to celebrate UV Safety Month. This poll will close July 28, 2021.

Trial shows treatment has acceptable safety profile, may improve visual function.

AAO develops task forces to evaluate academy, review outcomes in ophthalmology.

In order to benchmark 20/20 vision in an infant, the testing types and acuity being measured need to be altered.

Physicians should hospitalize ON patients to prevent blindness, possible death.

Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.

Structural photoreceptor abnormalities and an area of central sparing found.

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.